We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

101 hedge funds and large institutions have $323M invested in Cytokinetics in 2016 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

65.48% more ownership

Funds ownership: 0% → 65.48% (+65%)

32% more capital invested

Capital invested by funds: $246M → $323M (+$77.4M)

11% more funds holding

Funds holding: 91 → 101 (+10)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

15% less call options, than puts

Call options by funds: $358K | Put options by funds: $423K

17% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 35

Holders
101
Holders Change
+10
Holders Change %
+10.99%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
20
Increased
29
Reduced
35
Closed
9
Calls
$358K
Puts
$423K
Net Calls
-$65K
Net Calls Change
-$2.23M

Top Buyers

1
BFA
BlackRock Fund Advisors
California
+$7.43M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.46M
3
Morgan Stanley
Morgan Stanley
New York
+$1.72M
4
GC
Globeflex Capital
California
+$1.48M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.45M

Top Sellers

1
EC
EcoR1 Capital
California
-$8.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.22M
3
BI
BVF Inc
California
-$1.54M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$1.22M
5
Millennium Management
Millennium Management
New York
-$1.07M
Name Holding Trade Value Shares
Change 		Change in
Stake
PAM
76
Panagora Asset Management
Massachusetts
$137K -$881K -83,025 -88%
Citadel Advisors
77
Citadel Advisors
Florida
$137K -$316K -29,742 -72%
Lido Advisors
78
Lido Advisors
California
$134K +$5.09K +480 +5%
CCIA
79
Campbell & Co Investment Adviser
Maryland
$128K +$111K +10,500 New
Squarepoint
80
Squarepoint
New York
$125K +$109K +10,270 New
Legal & General Group
81
Legal & General Group
United Kingdom
$115K +$48K +4,525 +94%
Bank of America
82
Bank of America
North Carolina
$111K +$42.1K +3,969 +76%
PCM
83
Prelude Capital Management
New York
$66K +$26.5K +2,500 +86%
BlackRock
84
BlackRock
New York
$40K +$2.24K +211 +7%
PA
85
Parallel Advisors
California
$33K +$28.7K +2,700 New
AIM
86
Acrospire Investment Management
Illinois
$30K +$26.3K +2,478 New
Royal Bank of Canada
87
Royal Bank of Canada
Ontario, Canada
$27K +$22.7K +2,137 New
LTFS
88
Ladenburg Thalmann Financial Services
Florida
$24K – – –
BNP Paribas Financial Markets
89
BNP Paribas Financial Markets
France
$23.1K -$3.99K -376 -16%
MFS
90
MSI Financial Services
Massachusetts
$17K +$14.6K +1,375 New
GWM
91
Geneos Wealth Management
Colorado
$12K – – –
Walleye Trading
92
Walleye Trading
New York
$10K +$8.49K +800 New
AG
93
Advisor Group
Arizona
$9K – – –
LWM
94
Lenox Wealth Management
Ohio
$8K – – –
KF
95
Krilogy Financial
Missouri
$6K -$2.12K -200 -29%
Federated Hermes
96
Federated Hermes
Pennsylvania
$6K – – –
TRCT
97
Tower Research Capital (TRC)
New York
$6K +$2.69K +253 +113%
MAM
98
Meeder Asset Management
Ohio
$3K +$2.82K +266 New
HR
99
Howe & Rusling
New York
$2K – – –
Creative Planning
100
Creative Planning
Kansas
$1K – – –
1 2 3
4
5

CYTK Hedge Fund Activity: Q4 2016 in Review

101 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q4 2016, worth a combined $323M — up 32% from $246M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new CYTK positions and 9 closed out — a net gain of 11 holders — while 29 added to existing stakes and 35 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $7.43M. The largest seller was EcoR1 Capital, cutting an estimated $8.4M.

  • 101 institutional investors held Cytokinetics (CYTK) as of Q4 2016, up from 91 in Q3 2016.
  • Funds reported $323M of Cytokinetics stock for Q4 2016, up 32% quarter-over-quarter.
  • 20 funds opened new Cytokinetics positions in Q4 2016 and 9 closed out, a net change of +11 holders.
  • The largest Cytokinetics buyer in Q4 2016 was BlackRock Fund Advisors, an estimated $7.43M added.
  • The largest Cytokinetics seller in Q4 2016 was EcoR1 Capital, an estimated $8.4M sold.

Based on aggregated 13F filings for Q4 2016.